0

Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Coenzyme Q10 and Exercise Training Benefit Patients With Chronic Heart Failure

  • 작성자한진
  • 작성일2007-01-11 01:12:08
  • 조회수1804
  • 첨부파일첨부파일
NEW YORK (Reuters Health) Dec 29 - Oral coenzyme Q10 improves functional capacity, endothelial function, and left ventricular contractility in patients with chronic heart failure, according to a study in the November issue of the European Heart Journal. "Coenzyme Q10 (CoQ10), first isolated from beef heart mitochondria, is an essential component of the mitochondrial respiratory chain, and also has antioxidant properties," Dr. Romualdo Belardinelli, of Lancisi Heart Institute, Italy, and colleagues write. "However, its role in chronic heart failure (CHF) is not well defined." The study included 23 patients (mean age 59 years) with NYHA class II or III CHF secondary to ischemic heart disease (ejection fraction 37%). Patients were assigned to 4 weeks each of the following: oral CoQ10 (100 mg tid), CoQ10 plus supervised ET, (60% of peak VO2, 5 times/wk), placebo, and placebo plus ET. Of the 23 patients, 21 completed the study. No side effects were attributed to CoQ10. Supplementation with CoQ10 led to a four-fold increase in plasma CoQ10 level (from 0.82 mcg/mL to 3.64 mcg/mL, p < 0.0001). A significant decrease in plasma levels of uric acid (-3%, p < 0.0001) and a significant increase in HDL (+3%, p = 0.0588) were observed with CoQ10 supplementation. No significant changes in total cholesterol. LDL-C, triglycerides, and vitamin E levels were observed. CoQ10 treatment significantly improved peak VO2 (+9%, p = 0.0001). "Systolic wall thickening score index (SWTI) had similar improvements as EF both at rest and at peak dobutamine (-9% and -12%, respectively; p < 0.0001)," Dr. Belardinelli's team writes. "These improvements were related to changes in regional contractility." Patients treated with CoQ10 had significant improvements in the endothelium-dependent relaxation (+38%, p = 0.0021). Combining ET with oral CoQ10 was linked to more marked improvements in all parameters. "Oral CoQ10 improves functional capacity, endothelial function, and left ventricular contractility in CHF without any side effects," the authors conclude. Eur Heart J 2006;27:2675-2681.
Total406 [ page12/28 ]
No. 제목 작성자 작성일 조회수
241 Mitochondrial Damage Impairs Oxygen Metabolism After Intracerebral Hemorrhage 2007.01.11 한진 2007.01.11 2,141
240 Weight Loss Improves Heart Rate Recovery in Overweight and Obese Men With Features of the Metabolic Syndrome 2007.01.11 한진 2007.01.11 2,128
239 Metabolic Syndrome Independently Predicts Vascular Complications in Diabetes 2007.01.11 한진 2007.01.11 1,925
238 Metabolic Syndrome Helps Predict Cardiovascular Disease and Diabetes Risk 2007.01.11 한진 2007.01.11 4,116
237 미토콘드리아 DNA의 복제 첨부파일 2007.01.10 한진 2007.01.10 3,232
236 미토콘드리아에 관심 집중 2007.01.10 한진 2007.01.10 2,177
235 미토콘드리아 산화 스트레스로 인한 파킨슨병 기전 동정 2007.01.10 한진 2007.01.10 2,730
234 미토콘드리아 이동 변화에 따른 신경세포 기능 이상 동정 2007.01.10 한진 2007.01.10 2,170
233 세포의 기능에 영향을 주는 미토콘드리아 DNA 발견 2007.01.10 한진 2007.01.10 2,817
232 미토콘드리아 DNA조절 부위 변이가 알츠하이머병과 연관 2007.01.10 한진 2007.01.10 4,206
231 미토콘드리아 돌연변이가 혈압 및 콜레스테롤 이상과 관련 2007.01.10 한진 2007.01.10 2,371
230 암세포의 아킬레스腱은 미토콘드리아 2007.01.10 한진 2007.01.10 2,064
229 Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. 2007.01.06 한진 2007.01.06 3,717
228 A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. 2007.01.06 한진 2007.01.06 2,198
227 Uncoupling protein-3: clues in an ongoing mitochondrial mystery. 2007.01.06 한진 2007.01.06 2,508
처음 이전 11 12 13 14 15 16 17 18 19 20 다음 마지막